These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2967242)

  • 21. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis.
    Henriksen JH; Schütten HJ; Bendtsen F; Warberg J
    Liver; 1986 Dec; 6(6):361-8. PubMed ID: 2952859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.
    Bates ER; Shenker Y; Grekin RJ
    Circulation; 1986 Jun; 73(6):1155-61. PubMed ID: 2938846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease.
    Warner LC; Campbell PJ; Morali GA; Logan AG; Skorecki KL; Blendis LM
    Hepatology; 1990 Sep; 12(3 Pt 1):460-6. PubMed ID: 2144838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong F; Siu S; Liu P; Blendis LM
    Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humans.
    Obata K; Yasue H; Okumura K; Matsuyama K; Ogawa H; Kurose M; Saito Y; Nakao K; Imura H; Nobuyoshi M
    J Am Coll Cardiol; 1990 Jun; 15(7):1537-43. PubMed ID: 2140577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites.
    Jiménez W; Martinez-Pardo A; Arroyo V; Gaya J; Rivera F; Rodés J
    Am J Physiol; 1986 Apr; 250(4 Pt 2):F749-52. PubMed ID: 2938485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial natriuretic factor in cirrhotic patients with ascites.
    Gastroenterology; 1989 Apr; 96(4):1225-7. PubMed ID: 2522409
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma human atrial natriuretic peptide levels in patients with liver cirrhosis.
    Uemura K; Oguchi H; Kiyosawa K; Furuta S
    J Gastroenterol Hepatol; 1989; 4(2):167-74. PubMed ID: 2535228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic peptide in humans. Production and clearance by various tissues.
    Crozier IG; Nicholls MG; Ikram H; Espiner EA; Yandle TG; Jans S
    Hypertension; 1986 Jun; 8(6 Pt 2):II11-5. PubMed ID: 2941367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperresponsiveness to water immersion in sodium retaining cirrhotics: the role of atrial natriuretic factor.
    Campbell PJ; Leung WM; Logan AG; Debowski TE; Blendis LM; Skorecki KL
    Clin Invest Med; 1988 Dec; 11(6):392-5. PubMed ID: 2976331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of endothelin in cirrhosis.
    Asbert M; Ginès A; Ginès P; Jiménez W; Clària J; Saló J; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1993 May; 104(5):1485-91. PubMed ID: 8482460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
    Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
    Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
    Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
    Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis.
    Beutler JJ; Koomans HA; Rabelink TJ; Gaillard CA; Van Hattum J; Boer P; Dorhout Mees EJ
    Hepatology; 1989 Aug; 10(2):148-53. PubMed ID: 2526072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema.
    Shenker Y; Sider RS; Ostafin EA; Grekin RJ
    J Clin Invest; 1985 Oct; 76(4):1684-7. PubMed ID: 2932471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor.
    Rector WG; Adair O; Hossack KF; Rainguet S
    Gastroenterology; 1990 Sep; 99(3):766-70. PubMed ID: 2143159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.